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Abstract
Background: From the morphological appearance, it was impossible to distinguish terminal portal venules from
small lymphatic vessels in the portal tract even using histochemical microscopic techniques. Recently, D2-40 was
found to be expressed at a high level in lymphatic endothelial cells (LECs). This study was undertaken to elucidate
hepatic lymphatic vessels during progression of cirrhosis by examining the expression of D2-40 in LECs.
Methods: Surgical wedge biopsy specimens were obtained from non-cirrhotic portions of human livers (normal
control) and from cirrhotic livers (LC) (Child A-LC and Child C-LC). Immunohistochemical (IHC), Western blot, and
immunoelectron microscopic studies were conducted using D2-40 as markers for lymphatic vessels, as well as
CD34 for capillary blood vessels.
Results: Imunostaining of D2-40 produced a strong reaction in lymphatic vessels only, especially in Child C-LC. It
was possible to distinguish the portal venules from the small lymphatic vessels using D-40. Immunoelectron
microscopy revealed strong D2-40 expression along the luminal and abluminal portions of the cell membrane of
LECs in Child C-LC tissue.
Conclusion: It is possible to distinguish portal venules from small lymphatic vessels using D2-40 as marker.
D2-40- labeling in lymphatic capillary endothelial cells is related to the degree of fibrosis in cirrhotic liver.
Background
During cirrhosis, the hepatic microvascular phenotype is
transformed from sinusoids to continuous capillaries [1].
This crucial process includes excessive deposition of
extracellular matrix in the space of Disse. Eventually,
formation of basement membranes and defenestration
of endothelial cells occur, thereby compromising the
normal transfer of nutrients between sinusoidal blood
and hepatocytes. All metabolites exchanged between the
bloodstream and the hepatocytes pass through the space
of Disse that extends from the nonluminal side of the
sinusoidal endothelial cell to the microvilli of the hepa-
tocellular membrane, and is considered to be confluent
with the hepatic lymphatics of the portal tracts [2].
Increased lymph flow is known to occur in cases of dif-
fuse abnormalities of the liver architecture, e.g. fibrosis
and cirrhosis [3]. In human cirrhosis, increased lymph
production has been described repeatedly; dilated lymph
vessels were documented using angiography and compu-
ter tomographic scans in liver fibrotic and cirrhotic
patients [4].
Hepatic lymph vessel expansion and its functional
relation with blood hepatocyt i ce x c h a n g ec a p a c i t yh a v e
been studied in vivo by fluorescence microscopy in ani-
mal models of fibrosis [5]. Morphologically, liver tissue
from human patients with cirrhosis or obstructive jaun-
dice has been analyzed thoroughly using transmission
and scanning electron microscopy, and dilatation of the
lymphatic vessels has been reported [6]. Lymphatic ves-
sels on the liver surface have also been observed macro-
scopically during laparoscopy, and dilatation of these * Correspondence: yokomori@insti.kitasato-u.ac.jp
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diseases has also been reported [7].
Blood vessels are identifiable using several immuno-
histochemical methods. Immunostaining for a smooth
muscle actin, factor VIII-associated antigen, and alkaline
phosphatase (ALPase) are strongly positive in blood ves-
sels but negative or only weakly positive in lymphatic
vessels [8]. These staining methods have therefore been
used to differentiate between blood and lymphatic ves-
sels. In addition, 5-nucleotidase activity has been
reported to be higher in lymphatic vessels than in blood
vessels. A quantitative analysis of lymph vessels using
5-nucleotidase showed marked increases in lymph vessel
density and area in rat liver tissues affected by fibrosis
and cirrhosis [9]. Using the methods described above,
the numbers and areas of lymphatics were found to
differ significantly depending on the degree of liver
cirrhosis, but were not affected by the activity of
hepatitis [10]. Superficial lymphatic vessels have been
reported to be more clearly visible in cirrhotic liver [10].
Lymphatic vasculature has recently emerged as a pro-
minent area of research, especially in the identification
of lymphatic endothelial specific markers and regulators
such as vascular endothelial growth factor receptor
(VEGFR)-3, vascular endothelial growth factor (VEGF)-
C/D, homeobox prospero-like protein (PROX1), D2-40,
lymphatic vessel endothelial hyaluronan receptor-1
(LYVE-1), ephrinB2, and Forkhead Box C2 (FOXC2).
Furthermore, development of mouse models has laid the
foundation that supports our understanding of the
major steps controlling growth and remodeling of lym-
phatic vessels [11].
A widely used marker of lymphatic endothelial cells in
both normal and tumor tissues is LYVE-1, a homolog of
hyaluronan receptor CD44 [12]. LYVE-1 is expressed on
luminal and abluminal surfaces of lymphatic endothe-
lium, and on hepatic sinusoidal endothelial cells [13].
LYVE-1 expression is attenuated in cirrhotic nodules
and absent in HCC liver compared to the normal sinu-
soidal counterpart [13]. The monoclonal antibody D2-40
raised against a MW 40 kD membrane sialomucin
stained the endothelium of lymph vessels but did not
react with the endothelium of capillaries, arteries, and
veins in normal and neoplastic formalin-fixed paraffin-
embedded tissues [13]. Furthermore, D2-40 has been
shown to react with glycosylated and non-glycosylated
epitopes of gp36. This molecule is also identical to
podoplanin [14]. CD34 is a type 1 transmembrane sialo-
mucin mostly present on vascular endothelium in the
liver but has been reported on lymphatics in some stu-
d i e s .C D 3 4i sa b s e n tf r o mm o s ts i n u s o i d a le n d o t h e l i a l
cells in normal liver but expression increases during
capillarisation in chronic inflammatory disease and in
the sinusoidal-type vasculature within hepatocellular
carcinomas [15]. Sinusoidal capillarization indicated by
CD34 expression correlated with dedifferentiation of the
liver tissue during the course of cirrhosis [16].
In fact, D2-40 and podoplanin have been demon-
strated as the most sensitive and specific markers for
lymph vessel endothelium. The present study was
undertaken to elucidate human hepatic lymphatic ves-
sels using D2-40 antibodies during the course of cirrho-
sis progression, and to investigate the relation with liver
cirrhosis. Moreover, blood vessels were also investigated
using CD34 antibodies mainly as the blood vessel
endothelial markers.
Methods
Materials
Surgical liver samples were collected at the Kitasato Insti-
tute medical Center Hospital, Kitasato University and
School of Medicine, Keio University between 1997 and
2002. As controls, wedge biopsy specimens from normal
portions of the liver were obtained from six patients (five
male and one female; aged 63-72 years, mean 67.9 years)
who underwent surgical resection for metastatic liver car-
cinoma (all colonic carcinomas). Cirrhotic liver specimens
were obtained from a group of five patients (4 males and 1
female; aged 64-74 years, mean 67.4 years) with hepatocel-
lular carcinoma (HCC) and hepatitis C-related cirrhosis of
Child-Pugh grade A [17], who underwent hepatectomy
(Child A-LC group). Specimens were obtained from the
gross cirrhotic portions resected surgically. All patients
were evaluated before operation using the indocyanine
green (ICG) clearance test, and all had ICG less than15%.
Cirrhotic liver specimens were obtained from another
group of five patients (five males; aged 58-65 years, mean
61.2 years) with HCC and cirrhosis of Child-Pugh grade
C, who underwent liver transplantation (Child C-LC
group). All patients in this group had three or fewer
tumor nodules with maximal diameter not exceeding
5 cm, but no signs of vascular invasion [18].
Ethical Approval
The study protocols were approved by the Ethics Com-
mittee of the Kitasato Institute Medical Center Hospital,
Kitasato University.
Immunohistochemistry
Mouse monoclonal antibody D2-40 (Signet Laboratories,
Inc., Dedham, MA) was used at a dilution of 1:200, and
the streptavidin-biotin immunoperoxidase method was
used for detecting immune complexes. The sections
were deparaffinized and rehydrated. Then sections for
D2-40 detection were autoclaved for 7 min at 120°C in
10 mM citrate buffer solution (pH 6.0). After blocking
endogenous peroxidase with 0.03% hydrogen peroxide,
the sections were incubated with D2-40 antibodies
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room temperature for 30 min with goat anti-mouse
immunoglobulin conjugated to a peroxidase-labeled
amino acid polymer, as provided in the SAB-PO (M) Kit
(Nichirei Corp., Tokyo, Japan). The sections were coun-
terstained with hematoxylin.
Combined use of lymphatic vessel endothelial markers
with pan-endothelial markers, such as D2-40 with
CD34, is a practical method to distinguish between
blood vessels and lymphatic vessels [19,20]. Therefore,
we immunostained sequential sections with antibodies
against CD34 for immunohistochemical expression of
blood vessel endothelial cell markers. Sections were
treated with primary antibodies against CD34 (Dako) for
30 min at room temperature (RT) and subsequently
developed using the Envision system (Dako). Bound
antibodies were visualized by peroxidase reaction in a
3,3’-diaminobenzoic tetrahydrochloride (DAB) and H2O2
solution.
Computer-assisted morphometric analysis of the
lymphatic and vascular network
Morphometric variables were determined by labeling
lymphatic vessels with anti-human D2-40 and blood ves-
sels with anti-CD34 antibody. Three different portal
regions and regenerative fibrotic areas were assessed
separately for each section of cirrhotic liver. Briefly, the
immunostained sections were scanned using a light
microscope at low magnification (×40) and vessels were
counted using high magnification (×200; 0.304 mm
2/
field) in each of the regions. Image analysis was done
using a computer. Images were captured with the
microscope and digitalized using an internal frame-grab-
bing board (Photoshop CS4/Photoshop CS4 Extended;
Adobe Systems, Inc.). This procedure consisted of con-
verting the captured image in points or pixels according
to the red tone to assess the lymphatic capillary vessel
density (LCVD) or capillary blood vessel density
(CBVD). The number of pixels per square millimeter
was derived from image analysis [21].
Differences in vessel density were analyzed using one-
way ANOVA. A post-hoc Fisher’s analysis was performed
on statistically significant effects to detect differences
between the groups.
Immunogold-silver staining method for electron
microscopy
Liver tissues were fixed in periodate-lysine-parafomalde-
hyde (PLP). Semi-thin 5 μm sections were immersed for
15 min in three changes of 0.01% phosphate buffered
saline (PBS; pH 7.4). Then the sections were incubated
with mouse anti-D2-40 monoclonal antibody (Signet)
diluted 1:40 in 0.01 M phosphate buffered saline con-
taining 1% bovine serum albumin, overnight at 4°C in a
moisture chamber. After rinsing for 15 min in PBS
three times, the sections were incubated in 1.4 nm
colloidal gold-conjugated IgG antibody (Nanoprobes
Inc., Yaphank, NY) diluted 1:50 for 40 min. Finally, the
sections were physically developed using a silver
enhancement kit (Nanoprobe Silver Enhancement Kit;
Nanoprobes) [22]. For transmission electron microscopy,
the materials were treated for 15 min PBS three times
and fixed in 1.2% glutaraldehyde buffered with 0.01%
phosphate buffer (pH 7.4) for 1 h at 4°C, followed by a
graded series of ethanol solutions and postfixation with
1% osmium tetroxide in 0.01% phosphate buffer (pH
7.4). After embedding in Epon, ultrathin sections were
cut with a diamond knife on an LKB ultramicrotome.
They were then stained with uranyl acetate and
observed under a transmission electron microscope
(JEM-1200 EX; JEOL Tokyo, Japan) with 80-kV accel-
eration voltage.
The immunogold labeling of lymphatic endothelial cells
in the ultrathin sections was quantitated using the Mac
Measure software (NIH Image ver. 1.62). Lymphatic
endothelial cells around portal tracts (×4000) were
selected randomly. The gold particles per unit length of
membrane were counted (n =1 2 ) .S t a t i s t i c a ls i g n i f i c a n c e
of the difference between control and cirrhotic samples
was assessed using Student’s t-test, and p <0 . 0 5w a s
inferred as significant. Data are expressed as mean ± SEM.
Western blotting
Tissue samples were homogenized in 10 volumes of
homogenization buffer (20 mM Tris-HCl, pH 7.5, 5 mM
MgCl2,0 . 1m MP M S F ,2 0μM pepstatin A, and 20 μM
leupeptin) using a polytron homogenizer at setting 7 for
90 s. The membrane proteins thus obtained were used
for immunoblotting. Proteins (20 ng/ml) were separated
using SDS/PAGE and transferred onto polyvinylidene
difluoride membranes (NTN Life Science Products). The
blots were blocked with 5% (w/v) dried milk in PBS for
30 min, incubated with anti-D2-40 (Signet Laboratories)
diluted 1:500 and then CD34 (Abcam) diluted 1:5000 in
PBS containing 0.1% Tween 20. After rinsing in PBS,
color was developed using an ECL system (Super Signal
West Femto; Pierce Biotechnology Inc.). The bands
were visualized using a diaminobenzidine solution con-
taining 0.01% H2O2. The relative D2-40 signal intensity
was obtained by dividing the intensity of D2-40 signals
by that of GAPDH signals. Densitometric analysis of
Western blot was performed using the Scion Image soft-
ware (ver. Beta 4.02, Scion Corp., Frederick, MD). Data
are expressed as means ± SEM. Statistical analyses were
performed using one-way ANOVA followed by a post-
hoc test (Fisher’s PLSD) for multiple comparisons.
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Immunohistochemical findings for D2-40 and CD34
In human control liver, lymph vessels were identified
imunohistochemically as D2-40-positive and CD34-
negative, while blood vessels were D2-40-negative and
CD34-positive (Figures 1b and 1d). Positive imunoreac-
tivity of CD34 was observed in central vessels and portal
vessels, as well as terminal portal venules (Figures 1c
and 1d). Slight imunoreactivity for D2-40 was found in
the lymphatic vessels in the portal tract, some of which
were parallel to the hepatic arteries. Most vessels were
easily distinguishable as lymph vessels or blood vessels
by a combination of D-2 40 and CD34 staining, because
very few vessels were positive for both or negative for
both markers. Liver parenchyma showed very few or no
lymphatic vessels (Figures 1a and 1b).
In Child A-LC liver, CD34-labeled blood vessels and
D2-40-labeled lymphatic vessel in the fibrotic septa were
more abundant compared to those in the portal tract in
normal control liver (Figures 1e-h). Reaction products of
CD34 were more abundant in regenerative nodules than
in control liver (Figures 1g and 1h). Lymphatic vessels
labeled by D2-40 appeared dilated and irregular in dis-
tribution (Figures 1e and 1f).
In Child C-LC liver, the D2-40-labeled lymphatic ves-
sels were increased (Figures 1i and 1j). CD34 labeled
blood vessels were more numerous than in control or
Child C-LC liver (Figures 1k and 1l). Moreover, D2-40-
positive lymphatic vessels were markedly denser and
more variable in size than in Child A-LC liver.
Morphometry of lymphatic vessels based on D2-40
immunostaining and blood vessels based on CD34
immunostaining
In the portal tract, CBVD evaluated by CD34 immu-
nostaining were 0.0742 pixels/mm
3 in control, 0.1566
pixels/mm
3 in Child A-LC, and 0.1350 pixels/mm
3 in
Child C-LC, and was significantly higher in Child
C-LC (p = 0. 021) and Child A-LC (p <0 . 0 2 1 )t h a ni n
control, although there was no significant difference
between Child A-LC and Child C-LC (p =0 . 0 9 )
(Figure 2). In the portal tract, LCVD evaluated by D2-
40 immunostaining were 0.01459 pixels/mm
3 in con-
trol, 0.07692 pixels/mm
3 in Child A-LC and 0.229216
pixels/mm
3 in Child C-LC, and was significantly higher
in Child C-LC than in Child A-LC (p = 0.001) or con-
trol (p < 0.001), and tended to be higher in control
than in LC-A (p = 0.05) (Figure 2). Morphometry of
lymphatic vessels based on D2-40 immunostaining
showed a significant difference in of lymphatic vessel
density between the mild cirrhotic stage and end-stage
cirrhotic stage, and were prominently increased in the
end-stage cirrhotic stage.
Western blot for D2-40, CD34
To confirm the immunohistochemical results, we investi-
gated the protein expression of D2-40 and CD34 in con-
trol, Child A-LC and Child C-LC samples by Western
blotting. Both CD34 and D2-40 expressions were found
in control, Child A-LC and Child C-LC samples. Quanti-
tative densitometric data (expressed as D2-40/GAPDH
levels, n = 5 for each group) from multiple samples are
shown as mean ± SEM. D2-40 protein was expressed
abundantly in Child C-LC and only moderately in Child
A-LC and control livers, but CD34 protein was expressed
more abundantly in Child C-LC and Child A-LC than in
control liver (Figure 3).
Immunoelectron microscopic study
To clarify the ultrastructural localization of D2-40 and
how expression is altered in cirrhotic liver, we conducted
an immunoelectron microscopic study (Figure 4). In con-
trol liver tissue, electron-dense gold particles showing the
presence of D2-40 were few and mainly localized on the
luminal site of lymphatic capillary endothelial cells
around the portal tract (Figure 4a).
In Child A-LC, electron dense gold particles showing
the presence of D2-40 were increased compared to con-
trol liver, and were found not only on the luminal and
abluminal regions of the proliferated lymphatic capillary
endothelial cells (Figure 4b), but also on the basal sites
of the cell membrane on the lymphatic capillary.
In Child C-LC samples, electron dense gold particles
showing the presence of D2-40 were found on the pro-
liferated lymphatic capillar yE C s ,a n dw e r em o r ea b u n -
dant than in either control or Child A-LC (Figure 4c).
Moreover, gold particles demonstrating D2-40 were
more abundant than in Child A-LC, not only on the
luminal site, but also on basal sites of lymphatic capil-
lary vessels (Figure 4c). Scanty immunostaining for
D2-40 on hepatic sinusoids was observed at immunoe-
lectron microscopic level in both control and cirrhotic
liver tissues. Morphometric analysis of immunogold-
labeled D2-40 (Figure 4d) revealed that D2-40 labeling
was low in the lymphatic capillary endothelial cells of
control liver tissue (3.2 ± 0.2/2 μm). D2-40- labeling in
lymphatic capillary endothelial cells was significantly
higher in Child A-LC (11.2 ± 0.3/2 μm) than in control
(p < 0.05). D2-40 labeling in lymphatic capillary
endothelial cells was significantly higher in Child C-LC,
(18.2 ± 0.4/2 μm) than in control (p < 0.01) or Child
A-LC (p < 0.05).
Discussion and Conclusions
The present study demonstrated that D2-40 mAb is a
selective marker of lymphatic endothelium in normal
and cirrhotic liver tissues, and that this mAb does not
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Page 4 of 10Figure 1 Immunohistochemical studies of CD34 and D2-40. Immunohistochemical staining with monoclonal antibodies D2-40 and CD34 was
performed to examine lymphangiogenesis and angiogenesis in serial sections of liver samples obtained from normal portions of liver, Child-Pugh
grade A cirrhotic liver (Child A-LC), and Child-Pugh grade C cirrhotic liver (Child C-LC). White arrows denote capillary or blood vessel endothelial
cells. Black arrows denote lymph vessel endothelial cells. P denotes portal tracts or portal vein. C denotes central veins. A: Normal control liver
tissue. Positive imunoreactivity of CD34 is observed in central vessels and portal vessels, as well as terminal portal venules. a and b: Lymphatic
microvessels labeled by D2-40 immunostaining. c and d: Blood vessels labeled by CD34 immunostaining. White arrows show blood microvessels
labeled by monoclonal antibody of CD34 only. Original magnification: a, c: ×100; b, d (portal tract): ×400: B: Child A-LC liver tissue. e and f:
Lymphatic microvessels labeled by D2-40. g and h: Blood vessels labeled by CD34. CD34positive blood vessels are increased in cirrhotic liver. The
number of D2-40-labeled lymphatic vessels in the fibrotic septa and the intensity of D2-40 imunoreactivity are increased in Child A-LC compared to
the portal tract in normal control liver. Original magnification: e, g: ×100; f, h (fibrotic septa): ×400. C: Child C-LC liver tissue. i and j: Lymphatic
microvessels labeled by D2-40. k and l: Blood vessels labeled by CD34. D2-40-positive lymphatic vessels are more abundant compared to control
and Child A-LC liver tissues. Reaction products of CD34 are more abundantly located on hepatic sinusoids in regenerative hepatic nodules than in
the parenchyma of control liver tissue. Original magnification: i, k: ×100; j, l (fibrotic septa): ×400.
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Page 5 of 10react with the blood vessel endothelium, as demon-
strated by the following results. First, D2-40 reacted
with the endothelium of lymphatic channels, identified
by morphological appearance, in normal and cirrhotic
conditions. The endothelium of blood vessels including
arteries, veins, and capillaries were not immunostained
by D2-40 mAb. The sinusoids of normal liver showed
scanty immunoreactivity. We confirmed that combined
staining for D2-40 and CD34 is useful to distinguish
between lymphatic microvessels and blood capillary
vessels including hepatic arterial capillary and portal
venules in human liver tissues. This is the first report to
describe the analyses of the density of lymphatic vessels
in liver cirrhosis.
In the present study, density of lymphatics differed
significantly depending on the degree of liver fibrosis.
Superficial lymphatic vessels are more clearly visible in
cirrhosis, and the lymph vessels appear to be enlarged
when observed under a scanning electron microscope
[7]. Our histochemical resultss h o w e dt h a ti n t r a h e p a t i c
Figure 2 Morphometric analyses of lymphatic vessels based on D2-40 immunostaining and vascular vessels based on CD34
immunostaining in control, Child A-LC, and Child C-LC liver samples. Capillary blood vessel density (CBVD) and lymphatic capillary vessels
density (LCVD) are expressed in pixels/sq mm. Data are mean ± SEM. A: CBVD of control, Child A-LC and Child C-LC the entire patient
population (n = 28). Statistical analysis was performed using one-way ANOVA followed by Fisher’s PLSD. B: LCVD of control, Child A-LC and Child
C-LC liver samples. (n = 28). Statistical analysis was performed using one-way ANOVA, followed by Fisher’s PLSD.
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Page 6 of 10lymph vessels, i.e., non-superficial lymph vessels, are
also enlarged in patients with liver cirrhosis, especially
in those who had end-stage cirrhosis undergoing liver
transplantation (Child C-LC). This phenomenon is attri-
butable to increased lymph production, which results
from the impaired drainage of vascular flow from the
sinusoid to the central or terminal hepatic veins asso-
ciated with lobular distortion in patients with advanced
liver disease or cirrhosis. The most common cause of
ascites in cirrhosis is elevated pressure in the hepatic
circulation (portal hypertension). The elevated pressure
causes leakage of fluid from the lymph vessels in and
around the liver into the abdominal cavity. The role of
lymphatic abnormalities on the formation or reabsorp-
tion of ascites should be examined in further studies.
A previous study revealed that the number (density) of
blood vessels in the portal tract is highest during the
stage of mild fibrosis and that the area in the portal tract
is greater in normal liver and mild fibrosis than in mod-
erate and severe fibrosis [10]. These data indicate that
neither the number nor area of blood vessels increase
concomitantly with the portal area enlargement. These
changes in number and area of blood vessels differ from
those seen in lymphatic vessels [10]. The observation in
experimental animals of a strong negative correlation
between density of the lymphatic network in the sinusoid
and trans-sinusoidal macromolecular exchange suggests
that increased lymph flow is an important mechanism by
which fluid can bypass increased sinusoidal/postsinusoi-
dal resistance [5]. Furthermore, the lymphatic network
has been reported to be enlarged according to fibrotic
changes in cirrhotic rats [5]. Our results of immunohisto-
chemical and morphometric analyses of human liver
samples are in agreement with the findings of previous
findings, demonstrating that lymphatic vessels in the liver
increase in size and number with the progression of
chronic fibrosis, and are especially increased in end-stage
cirrhosis necessitating transplantation. The changes in
size and number of the lymph vessels differ considerably
from those seen in blood vessels. Several growth factors,
such as vascular endothelial growth factor (VEGF)-C are
involved in lymphatic angiogenesis [23]. These factors
promote the proliferation of lymphatic endothelial cells
and formation of lymphatic vessels.
In an in vitro study using primary human lung micro-
vascular lymphatic endothelial cells, small interfering
RNA (siRNA) mediated silence of podoplanin gene
expression has the dramatic effect of blocking capillary
tube formation in Matrigel, which clearly demonstrates
that early activation of RhoA in the lymphangiogenic
process -required for successful establishment of
the capillary network- is dependent on podoplanin
Figure 3 Western blots for D2-40, CD34 protein expression. CD34 and D2-40 protein expression in normal control, Child A-LC and Child
C-LC liver samples. Representative Western blots are shown. Quantitative densitometric data from multiple samples (expressed as D2-40/GAPDH,
n = 5 for each group) are shown as the mean value ± SEM. D2-40 protein level is high in Child C-LC liver samples and only moderate in control
and Child A-LC liver samples, but CD34 protein level is equally high in Child A-LC and Child C-LV liver samples but low in control liver samples.
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Page 7 of 10Figure 4 Immunoelectron microscopic findings. a: Distribution of D2-40 immunoreactivity at electron microscopic level in control liver tissue.
Electron micrograph of immunogold-silver enhancement staining of a liver lymphatic vessel (Ly) in control liver sample. Localization of D2-40 is
mainly on the plasma membrane of both luminal and abluminal surfaces of endothelial cells (arrowheads). b: Distribution of D2-40
immunoreactivity at electron microscopic level in Child A-LC liver tissue. Electron micrograph of immunogold-silver enhanced staining of a liver
lymphatic vessel (Ly). c: Distribution of D2-40 immunoreactivity at electron microscopic level in Child C-LC liver tissue. D2-40 immunoreactivity is
present along luminal and abluminal portions of the cell membrane (arrowheads) and is pronounced along cell processes. PV: portal venule; a:
capillary artery; Ly: lymphatic vessel; P: portal vein, PV(e): portal vein, c(e): capillary arterial endothelial cell, and Ly(e): lymphatic endothelial cell.
Scale bars: 2 μm. d: Morphometric analysis of immunogold-labeled D2-40. D2-40 labeling on lymphatic capillary endothelial cells is low in
control liver tissue (3.2 ± 0.2/2 μm). In Child A-LC liver tissue, D2-40-1 labeling on lymphatic capillary endothelial cells (11.2 ± 0.3/2 μm) is
significantly higher (p < 0.05) compared to control. In Child C-LC liver tissue, D2-40 labeling on lymphatic capillary endothelial cells (18.2 ± 0.4/2
μm) is significantly higher (p < 0.01) compared to control and also significantly higher (p < 0.05) compared to Child A-LC.
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suggest that the factors associated with increased density
of lymphatic and blood vessels might be different.
Although we did not investigate the mechanisms of dila-
tation and proliferation of lymph vessels in different
stages of cirrhosis, these changes are thought to result
from the disturbance of microcirculation associated with
liver fibrosis and lobular distortion.
Regarding lymphatic endothelial cell marker, LYVE-1
reactivity is marked in cirrhotic liver, and is expressed also
on hepatic sinusoidal endothelial cell, especially in normal
liver tissues [13]. However, some investigators have ques-
tioned the specificity of LYVE-1 for lymphatic endothelial
cells [13]. This study showed scanty D2-40 immunostain-
ing on sinusoids at immunoelectron microscopic level in
both control and cirrhotic tissues. A previous study using
corrosion casting/scanning electron microscopy showed
that the portal lymphatic networks develop around the
portal triads, and extend distally as far as the terminal por-
tal tract [25]. No tendency for the portal lymphatic vessels
to run preferentially along the interlobular arteries, veins,
or bile ducts was observed. These findings apparently sup-
port the hypothesis that the portal lymph comes mainly
from the hepatic sinusoids.
It has long been a puzzle of how fluid in the space of
Disse reaches the lymphatics in the portal tract. The
limiting plate of heptocytes possesses many pores
(1-3 μm in diameter) that open to the space of Mall.
The pores are continuous with the channels between
hepatocytes and open into the space of Disse. The
space of Disse is connected through these channels to
the space of Mall, and then drains through the intersti-
tial space of the portal tracts to enter interlobular lym-
phatics [26]. Lymph vessels and branches of the portal
vein are readily discerned in the portal tracts. A
marked increase in the number of lymph vessels was
noted in the portal tract of idiopathic portal hyperten-
sion and primary biliary cirrhosis compared to that of
the control liver [27,28]. Advanced cirrhosis is thought
to result from increased lymph production, which in
turn arises from disturbance of the microcirculation
associated with portal hypertension.
In the present study, D2-40 was mainly localized in
lymphatic endothelial cells and the expression in the
regenerative nodul e sb e c a m es t r o n g e ra sc i r r h o s i s
advanced. At immunoelectron microscopic level, we
were able to distinguish between the portal venule,
capillary artery, and lymphatic endothelial cells.
A limitation of the present study is that we investi-
gated a small number of samples (five in each group),
which may be a disadvantage in the analysis and com-
parison of vessel density between study groups. A larger
number of samples should be examined to confirm the
present finding.
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